Should adjuvant trastuzumab be offered in very early-stage (pT1a/bN0M0) HER2- neu -positive breast cancer? A current debate

By Petrelli Fausto  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 401-408

Humana Press, Inc

Access to resources Recommend Favorite

Expression and association of HER2 with prognosis in early-stage (T1-T2N0M0) non-small cell lung cancer

By Xia Qing  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1719-1725

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic Significance of Lymph Node Metastasis and Clear Cell Histology in Ovarian Carcinoma Limited to the Pelvis (pT1M0 and pT2M0)

By Sakuragi N.   Yamada H.   Oikawa M.   Okuyama K.   Fujino T.   Sagawa T.   Fujimoto S.  

Gynecologic Oncology, Vol. 79, Iss. 2, 2000-11 ,pp. : 251-255

Elsevier

Access to resources Recommend Favorite

Prognostic Value of Quantitative Cytometry in a Series of 415 T1T2/N0N1/M0 Breast Cancer Patients--Preliminary Results

By Bolla M.   Seigneurin D.   Winckel P.   Marron-Charriere J.   Panh M.H.   Pasquier D.   Chedin M.   Payan R.   Merlin F.   Colonna M.  

European Journal of Cancer, Vol. 32, Iss. 10, 1996-09 ,pp. : 1680-1685

Elsevier

Access to resources Recommend Favorite

Proton beam therapy for locally advanced and unresectable (T4bN0M0) squamous cell carcinoma of the ethmoid sinus: A report of seven cases and a literature review

By                  

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 201-205

Spandidos Publications

Access to resources Recommend Favorite